Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Virginia Commonwealth University
Study ID
NCT05974644
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Amyloidosis, Hereditary

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Registry — OTHER
    The purpose of this registry is to collect and store health information from people who are carriers of the gene known to cause hereditary amyloidosis and those with a confirmed diagnosis of the disease.

Study Details

The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who meet the inclusion criteria and none of the exclusion criteria until 1000 patients are enrolled, at which point in time the study investigators will evaluate whether further patient accrual is meaningful.

Key Dates

Start date
Jul 31, 2026
Status verified
Jun 2026
Primary completion
Dec 1, 2030
Completion
Dec 1, 2030

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Asymptomatic carriers
  • Arm: Patients with cardiac hereditary transthyretin amyloidosis (hATTR)

Primary Outcome Measure

The predictors and incidence of amyloidosis [ Time Frame: 15 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Virginia Commonwealth UniversityRichmondVirginia23298
Keyur Shah, MD
[email protected]
804-828-4571
Keyur Shah, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Richmond, VA

By research site
Virginia Commonwealth University· Richmond, VA

Related Studies